By inhibiting protein production, metformin downregulates antiapoptotic Mcl-1 and Bcl-xl expression, resulting in a synergistic anti-tumor effect with ABT-199 in AML[30]. The gene discussed is MCL1; the disease is acute myeloid leukemia.